Table 2 Outcomes of the included patients
Variable | Value |
|---|---|
In-hospital mortality, n (%) | 45 (30.2%) |
 Cause of death |  |
  Multiple organ failure, n (%) | 25 (55.6%) |
  Heart failure, n (%) | 16 (35.6%) |
  Hemorrhagic shock, n (%) | 2 (4.4%) |
  Sepsis, n (%) | 2 (4.4%) |
In hospital time (d) | 16.20 ± 4.90 |
Onset time of hyperbilirubinemia (d) | 2.32 ± 1.57 |
ICU stay time (d) | 5.09 ± 5.47 |
Postoperative AKI, n (%) | 120 (80.5%) |
 Stage of AKI |  |
  Stage 1, n (%) | 69 (46.3%) |
  Stage 2, n (%) | 20 (13.4%) |
  Stage 3, n (%) | 31 (20.8%) |
CRRT, n (%) | 27 (18.1%) |
Use of ECMO, n (%) | 9 (6.0%) |
Use of IABP, n (%) | 4 (2.7%) |
Use of tracheotomy, n (%) | 5 (3.4%) |
Use of vasoactive agent, n (%) | 109 (73.2%) |
Duration of mechanical ventilation (d) | 2.83 ± 3.14 |
The amount of blood transfusion (U) | 31.32 ± 33.60 |